Faber, Jens

Risk of over- and under- treatment with levothyroxine in primary care in Copenhagen, Denmark.

la Cour, J. L., Medici, B. R., Grand, M. K., Nicolaisdottir, D. R., Lind, B., Faber, J., Andersen, C. L., & Nygaard, B. (2021) · European Journal of Endocrinology

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 22

Peripheral markers of thyroid function: the effect of T4 monotherapy vs T4/T3 combination therapy in hypothyroid subjects in a randomized crossover study

Schmidt, U., Nygaard, B., Jensen, E. W., Kvetny, J., Jarløv, A., & Faber, J. (2013) · Endocrine Connections

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 17

Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis

Tougaard, N. H., Faber, J., & Eldrup, E. (2019) · BMJ Case Reports

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 16

A radioimmunoassay of serum 3,5-diiodothyronine

Kirkegaard, C., Faber, J., Siersbæk-Nielsen, K., & Friis, T. (1981) · Acta Endocrinologica

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 13

The effect of starvation and refeeding with oral versus intravenous glucose on serum 3,5-,3,3'-and 3'-5'-diiodothyronine and 3'-monoiodothyronine

Jædig, S., & Faber, J. (1982) · Acta Endocrinologica

Thyroid Disorders and TreatmentsDietary Effects on Health

Cited by 10

Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study

Frøssing, S., Nylander, M., Aziz, M., Skouby, S. O., Kistorp, C., & Faber, J. (2017) · Gynecological Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3